Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents — Pediatrics (2019)• Drug: atomoxetineDOI
- Attention deficit hyperactivity disorder: diagnosis and management (NICE guideline NG87) — NICE Guideline NG87 (2018)• Drug: atomoxetineOpen access
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: atomoxetineDOIPMID
- A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder — American Journal on Addictions (2010)• Drug: atomoxetinePMID